USAQOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
QHSLab, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.32+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.38M
- P/E (TTM)
- –
- Dividend yield
- –
QHSLab statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | QHSLab | Industry median |
|---|---|---|
| Market Cap | $4.81M | $230.55M |
| Enterprise Value | $4.49M | $202.97M |
| PS Ratio | 1.59 | 3.10 |
| PB Ratio | 3.09 | 3.04 |
| P/TBV Ratio | 15.66 | 4.43 |
Enterprise value
| Measure | QHSLab | Industry median |
|---|---|---|
| EV / Sales | 1.49 | 2.91 |
| EV / EBITDA | 29.04 | 19.74 |
| EV / EBIT | 54.38 | 24.80 |
Income (trailing twelve months)
| Measure | QHSLab | Industry median |
|---|---|---|
| Revenue | $3.02M | $102.39M |
| Gross Profit | $2.04M | $60.36M |
| Operating Income | $82.62K | -$4.31M |
| Net Income | -$390.73K | -$6.57M |
| EBITDA | $154.73K | -$1.98M |
| EPS (Diluted) | -$0.03 | -$0.08 |
Margins
| Measure | QHSLab | Industry median |
|---|---|---|
| Gross Margin | 67.7% | 55.2% |
| Operating Margin | 2.74% | -6.04% |
| Profit Margin | -13.0% | -10.5% |
| EBITDA Margin | 5.13% | -2.67% |
Returns
| Measure | QHSLab | Industry median |
|---|---|---|
| Return on Equity (ROE) | -85.4% | -18.2% |
| Return on Assets (ROA) | -21.4% | -13.3% |
| Return on Invested Capital (ROIC) | 30.4% | -3.69% |
| Return on Capital Employed (ROCE) | 5.30% | -9.07% |
Growth
| Measure | QHSLab | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 24.6% | 8.85% |
| Revenue Growth (3Y CAGR) | 29.4% | 7.08% |
| Revenue Growth (5Y CAGR) | 84.9% | 11.8% |
Balance sheet
| Measure | QHSLab | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $317.39K | $36.66M |
| Net Cash (Debt) | $317.39K | $3.92M |
| Net Cash Per Share | $0.02 | $0.28 |
| Equity (Book Value) | $1.56M | $55.33M |
| Book Value Per Share | $0.10 | $2.87 |
| Tangible Book Value | $307.11K | $10.79M |
| Working Capital | $307.11K | $56.72M |
Financial position
| Measure | QHSLab | Industry median |
|---|---|---|
| Current Ratio | 1.82 | 2.48 |
| Quick Ratio | 1.76 | 1.53 |
| Interest Coverage | 0.68 | -1.85 |
Cash flow (trailing twelve months)
| Measure | QHSLab | Industry median |
|---|---|---|
| Operating Cash Flow | -$463.66K | -$566.22K |
Efficiency
| Measure | QHSLab | Industry median |
|---|---|---|
| Asset Turnover | 1.66 | 0.58 |
| Inventory Turnover | 38.16 | 2.21 |
| Revenue Per Employee | $251.42K | $322.92K |
| Profits Per Employee | -$32.56K | -$51.88K |
| Employee Count | 12 | 185 |
Dividends and yields
| Measure | QHSLab | Industry median |
|---|---|---|
| Earnings Yield | -8.12% | -6.88% |
Shares
| Measure | QHSLab | Industry median |
|---|---|---|
| Shares Outstanding | 15,032,800 | 44,302,700 |
| Shares Change (YoY) | 33.5% | 3.36% |
| Shares Change (QoQ) | 0.00% | 0.27% |
| Float | 8,914,460 | 37,462,700 |
| Shares Held by Insiders | 40.7% | 10.5% |
Scores
| Measure | QHSLab | Industry median |
|---|---|---|
| Altman Z-Score | 6.70 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from QHSLab's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.